Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
University Hospital Cologne · John Radcliffe Hospital · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
747
total citations
- FWCI
- 39.89
- Percentile
- 100%
- References
- 23
Citations per year
Authors
8- OAOliver A. CornelyCorresponding
University Hospital Cologne
- DWDerrick W. Crook
John Radcliffe Hospital
- RERoberto Esposito
Azienda Unita' Sanitaria Locale Di Modena
- APAndré Poirier
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
- MSMichael Somero
Desert AIDS Project
Topics & keywords
Topics
Keywords
- Fidaxomicin
- Medicine
- Clostridium difficile
- Vancomycin
- Internal medicine
- Clinical endpoint
- Population
- Diarrhea
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.